FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:2294-2295 May 25, 2006 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: On February 9, 2006, a Food and Drug Administration (FDA) advisory panel recommended that stimulant drugs prescribed for attention deficit–hyperactivity disorder (ADHD) carry warnings about the potential for an increased risk of sudden death and cardiovascular problems such as hypertension, cardiac arrest, arrhythmias, and stroke.¹ Although stimulant drugs are known to cause adverse cardiovascular effects,^2,3 little is known about the incidence and type of adverse events in the community setting. To explore this issue, we examined adverse events from stimulant medications prescribed for the treatment of ADHD. We used data from the National Electronic Injury Surveillance System–Cooperative . . . [Full Text of this Article]

This article has been cited by other articles:

• Popovic, B., Bhattacharya, P., Sivaswamy, L. (2009). Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder. Am J Health Syst Pharm 66: 2005-2012 [Abstract] [Full Text]  
• Setlik, J., Bond, G. R., Ho, M. (2009). Adolescent Prescription ADHD Medication Abuse Is Rising Along With Prescriptions for These Medications. Pediatrics 124: 875-880 [Abstract] [Full Text]  
• Winterstein, A. G, Gerhard, T., Shuster, J., Zito, J., Johnson, M., Liu, H., Saidi, A. (2008). Utilization of Pharmacologic Treatment in Youths with Attention Deficit/Hyperactivity Disorder in Medicaid Database. The Annals of Pharmacotherapy 42: 24-31 [Abstract] [Full Text]  
• Winterstein, A. G., Gerhard, T., Shuster, J., Johnson, M., Zito, J. M., Saidi, A. (2007). Cardiac Safety of Central Nervous System Stimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Pediatrics 120: e1494-e1501 [Abstract] [Full Text]